Evidence map›Paper›PMID 39843356›Full record

ArticleBMJ open respiratory research2025

Twelve barriers to COPD diagnosis in France: a comparative qualitative study.

Guillaume Roucoux, Elisabetta Scanferla, Mathieu Delorme, Laurie Fraticelli, Lize Kiakouama Maleka, Cécilia Nocent-Ejnaini, Annaig Ozier, Maxime Patout, Olivier Le Rouzic, Maéva Zysman and 1 more

Abstract readComparative Study
In one paragraph

Article in BMJ open respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Optimizing COPD Care in Belgium: A Multidisciplinary Expert Consensus on Cardiopulmonary Risk Management.International journal of chronic obstructive pulmonary disease · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Guillaume RoucouxIndependent researcher, Paris, France contact@guillaumeroucoux.com.ORCID http://orcid.org/0000-0001-7181-9898
Elisabetta ScanferlaParis Cité University, Paris, Île-de-France, France.
Mathieu DelormeCardio-Thoracic Research Centre Bordeaux, Bordeaux, Aquitaine, France.ORCID http://orcid.org/0000-0001-8506-2021
Laurie FraticelliUniversity Lyon 1 Laboratory Systemic Health Course P2S, Lyon, Auvergne-Rhône-Alpes, France.
Lize Kiakouama MalekaLa Croix-Rousse Hospital, Lyon, Auvergne-Rhône-Alpes, France.
Cécilia Nocent-EjnainiCentre Hospitalier de la Côte Basque, Bayonne, Aquitaine, France.
Annaig OzierClinique Saint Augustin, Bordeaux, Aquitaine, France.
Maxime PatoutPulmonology and Sleep Department, Sorbonne University, Paris, France.
Olivier Le RouzicInserm U1019, University of Lille, F-59000 Lille, France.
Maéva ZysmanCHU de Bordeaux, Bordeaux, France.ORCID http://orcid.org/0000-0003-1459-2409
ABCD Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) is a common treatable disease often diagnosed in patients with risk factors after a prolonged period with suggestive symptoms. Our qualitative study aimed to identify barriers to establishing diagnosis in the natural history of this condition.

methodsAn inductive thematic analysis was performed on structured interviews with patients, general practitioners (GPs) and pulmonologists in France. Inclusion depended on criteria to generate two purposive samples (patients and physicians). Recruitment occurred online. Data collection proceeded until 15 patients and 15 physicians (eight pulmonologists, seven GPs) were interviewed. Data saturation was checked and achieved. The interviews were transcribed and coded in NVivo and triangulated between two researchers. The article respects the consolidated criteria for reporting qualitative research guidelines.

resultsThree phases in the patients' clinical pathway to diagnosis and 12 barriers were found: Phase 1 (symptoms before consultation; n=4), lack of COPD knowledge, symptom denial, fear of lung cancer, and delayed general practice consultations; Phase 2 (primary care; n=3), letting bronchitis become chronic, priority to diseases with similar symptoms and/or more serious diseases, lack of COPD screening devices, time and curative treatments; Phase 3 (specialised medicine; n=5), treatment before diagnosis, late referral to pulmonologists, difficulty in accessing specialists and examination results, patient's reluctance to undergo further examinations, and need for additional tests to confirm a diagnosis.

conclusionPeople unaware of their COPD condition can encounter up to 12 barriers, which may combine before obtaining a formal diagnosis. Patients, GPs, pulmonologists and the state health authorities share responsibility for addressing these barriers and enhancing the care pathway.

Indexed as

Health Knowledge, Attitudes, PracticePulmonary Disease, Chronic ObstructiveAdultAgedDelayed DiagnosisFemaleFranceGeneral PractitionersHealth Services AccessibilityHumansMaleMiddle AgedPrimary Health CarePulmonologistsQualitative ResearchReferral and ConsultationCOPD PathologyPhysical ExaminationPulmonary Disease, Chronic Obstructive

Identifiers

PMID39843356
PMCPMC11759880

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.